Board of Directors

Bruce Shenitz
Mr. Shenitz is a writer, editor, and information professional living in New York. He was formerly the deputy editor of Out magazine, and before that, a reporter at Newsweek for more than 10 years. Mr. Shenitz holds degrees from Yale University. His partner of 20 years–and husband of one year–died of leukemia in February 2011.

Vincent Santillo, MD
Dr. Vincent Santillo is an internist in New York, New York and is affiliated with Bellevue Hospital Center. He received his medical degree from Columbia University College of Physicians & Surgeons Dr. Santillo has written several peer reviewed articles and book chapters on Prostate Cancer treatment. He earned a MBA from Columbia University and a BS in Economics from the University of Pennsylvania, Wharton School of Business. Dr Santillo was diagnosed and treated for prostate cancer at age 33.

Keith Shepard
Mr. Sheppard is a internationally respected electric power generation consultant. Mr. Sheppard was diagnosed with locally advanced prostate cancer in 2009 and is widely known as a national prostate cancer advocate. Mr. Shepard holds engineering degrees from University of Missouri and Carnegie-Mellon University.

Board of Advisors

Thomas O. Blank, PhD
Department of Human Development and Family Studies, University of Connecticut
Dr, Blank is a social psychologist, focusing on  the psychosocial of cancer, aging, masculinity and GLBT health issues.  Dr. Blank has also written about his own journey as a prostate cancer survivor. Dr. Blank earned  his Ph. D. in Psychology from Columbia University.

Joel Conarroe
President Emeritus, John Simon Guggenheim Foundation, former president, PEN American Center, former dean, University of Pennsylvania and one of America’s leading philanthropists and literary scholars.

Phil Golz
Phil Golz is an entrepreneur and healthcare innovation specialist who has worked in healthcare roles for almost 20 years in the United States, Europe and Latin America.  He held a number of roles within the Pharmaceutical industry (Janssen, GlaxoSmithKline and ViiV Healthcare) where he specialized in leading technology and innovation groups and more recently led the commercial development of HealthUnlocked, the worlds leading Social Network for health, as well as launching and leading their US office. Today, he advises healthcare non-profits and technology companies in the US and Europe, with a mission to improve patient care and outcomes through technology and innovation.

David Latini, PhD
Dr. Latini is a clinical health